drugset / Trial / NCT06006702

A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants

NCT06006702 ↗

Phase 1 Active not recruiting 60 enrolled Tyra Biosciences, Inc
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the relative bioavailability of capsule and tablet formulations of TYRA-300-B01, and to evaluate the safety, tolerability, and food effect of TYRA-300-B01 tablets in healthy adult participants.

Timeline

Start
2023-10-16
Primary completion
2025-05
Completion
2025-07

Drugs

EvaluationDrugModalityDoseRoute
Subject TYRA-300-B01 Unknown — Oral

Indications

No indication recorded.